| 抗体类型 | Primary Antibodies |
|---|---|
| 免疫原 | Polypeptide |
| 克隆性 | Polyclonal |
| 同种型 | IgG |
| 宿主 | Rabbit |
| 已测试的应用 | ELISA |
| 物种反应性 | HumanMouseRat |
| 浓度 | 1mg/ml |
| 纯化 | Protein A |
| 基因名称 | OPRM1 |
| 基因别名 | LMOR; M-OR-1; MOP; MOP-R; MOR; MOR-1; MOR-1O; MOR1; MORA; muOR; OPRM; Oprrm1 |
| 基因全称 | opioid receptor mu 1 |
| 基因简介 | This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013] |
| 蛋白别名 | exon 1 splice variant; exon 4 splice variant; G-protein coupled receptor; GPCR; GPCR; MOR-1K1; hMOP; KIAA0403; M-OR-1; MOP receptor; MOR-1; MOR-1A; MOR-1BI; MOR-1BII; MOR-1C; MOR-1CII; alternatively spliced; MOR-1Eiii; MOR-1Eiv; MOR-1F; MOR-1P; MOR-1Q; MOR-1R; MOR-1T; MOR-1U; MOR1; MOR3; Mu class opiate receptor; mu opiate receptor; mu opioid receptor hMOR-1a; mu opioid receptor MOR-1BI; mu opioid receptor MOR-1P; MUOR1; Opioid mu receptor; Opioid Receptor; opioid receptor B; OTTHUMP00000017463; rMOR-1G2; rMOR-1H2; rMOR-1I2 |
| 分子量 | 44kDa |
| Uniprot ID | P35372 |
| 修饰 | Unmodification |
| 标记 | Unconjugated |
| 亚细胞定位 | Cell membrane;Cell projection, axon;Perikaryon;Cell projection, dendrite;Endosome |
| 产品形态 | Liquid |
| 缓冲液 | Purified antibody in PBS with 0.05% PC300. |
| 保存条件 | Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C long term. Avoid freeze / thaw cycle |
请在以下方框中输入您的动物实验信息后点击计算，可以得到母液配置方法和体内配方的制备方法：
比如您的给药剂量是10 mg/kg，每只动物体重20 g，给药体积100 μL， 一共给药动物10只，您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O， 那么您的工作液浓度为2 mg/mL。
母液配置方法：2 mg 药物溶于 100 μL DMSO （ 母液浓度为 20 mg/mL ）, 如您需要配置的浓度超过该产品的溶解度，请先与我们联系。
体内配方的制备方法： 取 100 μL DMSO 母液， 添加 400 μL PEG300 混匀澄清， 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例，并不是具体某个化合物的推荐配制方式，请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如： DMSO， PEG300， PEG400， Tween 80， SBE-β-CD， 玉米油等， 均可在诺渊网站点击购买。
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL Saline/PBS/ddH2O，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
